IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,486,000 | -8.4% | 5,200,000 | 0.0% | 0.12% | -20.5% |
| Q1 2022 | $5,988,000 | -30.6% | 5,200,000 | -32.5% | 0.16% | -29.4% |
| Q4 2021 | $8,629,000 | -5.4% | 7,700,000 | 0.0% | 0.22% | -15.3% |
| Q3 2021 | $9,119,000 | -0.1% | 7,700,000 | 0.0% | 0.26% | +1.6% |
| Q2 2021 | $9,132,000 | +7.0% | 7,700,000 | 0.0% | 0.26% | -16.3% |
| Q1 2021 | $8,532,000 | -1.1% | 7,700,000 | 0.0% | 0.31% | +1.3% |
| Q4 2020 | $8,628,000 | +12.0% | 7,700,000 | 0.0% | 0.30% | +8.2% |
| Q3 2020 | $7,704,000 | – | 7,700,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 30,477,080 | $31,017,758 | 1.54% |
| SHENKMAN CAPITAL MANAGEMENT INC | 17,691,000 | $17,931,726 | 1.34% |
| BRAIDWELL LP | 37,509,000 | $37,250,188 | 1.18% |
| III Capital Management | 16,200,000 | $16,068,483 | 0.81% |
| DLD Asset Management, LP | 7,500,000 | $7,471,875 | 0.80% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 34,375,000 | $34,057,674 | 0.73% |
| Worth Venture Partners, LLC | 1,034,000 | $1,029,476 | 0.61% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 40,200,000 | $39,922,620 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,055,000 | $3,041,634 | 0.07% |
| Leucadia National | 7,149,000 | $7,051,572 | 0.06% |